Resources

Type of publications
Regions
Diseases

5192 results found

2023 ∙ Cheng, M. Q. Li, R. Weng, Z. Y. Song, G.

Relative effectiveness of bivalent COVID-19 vaccine: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Yeo, S. Kim, H. Lee, J. Yi, J. Chung, Y. R.

Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Rachman, M. J. Kalanjati, V. P. Rimbun, R. Khadijah, F.

Retinal Vein Occlusion Amongst People Vaccinated by mRNA- and Viral Vector- COVID-19 Vaccines: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Ramasauskaite Rama Grinciute Grinciūtė, D.

Review of short-term and long-term adverse effects of covid-19 vaccination during pregnancy

  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Middleton, Bianca F. Danchin, Margie Fathima, Parveen Bines, Julie E. Macartney, Kristine Snelling, Thomas L.

Review of the health impact of the oral rotavirus vaccine program in children under 5 years in Australia: 2006 - 2021

  • Western Pacific
  • Australia
  • Newborn
  • Children
  • Rotavirus
  • Coverage
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Silva, P. B. R. Silva, G. D.

Risk and characteristics of attacks occurring after vaccination in patients with neuromyelitis optica spectrum disorders: A systematic review and meta-analysis

  • All age groups
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Tsampasian, V. Elghazaly, H. Chattopadhyay, R. Debski, M. Naing, T. K. P. Garg, P. Clark, A. Ntatsaki, E. Vassiliou, V. S.

Risk Factors Associated With Post-COVID-19 Condition A Systematic Review and Meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Marchand, G. Masoud, A. T. Medi, S.

Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-analysis of self-controlled case series studies

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Lin, Y. C. Chang, C. H. Su, W. J. Yang, C. H. Wang, J. T.

Risk of Coronavirus Disease 2019 Messenger RNA Vaccination-Associated Myocarditis and Pericarditis - A Systematic Review of Population-Based Data

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Lin, Y. C. Chang, C. H. Su, W. J. Yang, C. H. Wang, J. T.

Risk of Coronavirus Disease 2019 Messenger RNA Vaccination-Associated Myocarditis and Pericarditis – A Systematic Review of Population-Based Data

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...